# US 2023/0147050 A1 · Method For Extracting And Separating Flavonoids From Lindera Aggregata Leaves

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0147050 A1
- Document ID: US20230147050A1
- Status: Published application
- Kind: A1
- Application number: 17/752,168
- Filed: 2022-05-24
- Published: 2023-05-11
- Earliest claimed: 2021-11-10
- Assignees: Ningbo Municipal Hospital of T.C.M.
- Applicants: Ningbo Municipal Hospital of T.C.M.
- Inventors: Xin Peng; Chu Chu; Yanfang Zou; Shengqiang Tong
- Web page: https://patentgrep.com/patent/US20230147050A1

## CPC

- C07H 1/08: from natural products
- B01D 15/1807: {using counter-currents, e.g. fluidised beds}
- C07H 17/07: Benzo[b]pyran-4-ones
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present disclosure provides a method for extracting and separating flavonoids from Lindera aggregata leaves. The method includes: mixing Lindera aggregata leaves with an adsorbent, conducting elution with a matrix solid-phase dispersion (MSPD) extraction method, followed by concentration to obtain a Lindera aggregata leaf extract; conducting primary separation and secondary separation on the Lindera aggregata leaf extract by high-speed counter-current liquid chromatography (HSCCC), to separate quercetin-3-O-β-D-arabinofuranoside, a mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside, quercetin-3-O-rhamnopyranoside, and kaempferol-7-O-α-L-rhamnopyranoside; where a second solvent system used in the secondary separation includes ethyl acetate, n-butanol, an addictive and water, and the addictive includes cyclodextrin. The method has a short separation period, high separation efficiency, and less impurities during purification and separation of the flavonoids from the Lindera aggregata leaves.

## Claims

### Claim 1

A method for extracting and separating flavonoids from Lindera aggregata leaves, comprising the following steps:
mixing Lindera aggregata leaves with an adsorbent uniformly, conducting extraction by a matrix solid-phase dispersion (MSPD) extraction method, and conducting elution and concentration to obtain a Lindera aggregata leaf extract;
conducting primary separation on the Lindera aggregata leaf extract by high-speed counter-current liquid chromatography (HSCCC), to obtain quercetin-3-O-β-D-arabinofuranoside, a mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside, quercetin-3-O-rhamnopyranoside, and kaempferol-7-O-α-L-rhamnopyranoside; wherein a first solvent system used in the primary separation comprises ethyl acetate, n-butanol, n-hexane, glacial acetic acid, and water; and
conducting secondary separation on the mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside by the HSCCC, to separate the quercetin-3-O-β-D-glucoside from the quercetin-5-O-β-D-glucoside; wherein a second solvent system used in the secondary separation comprises the ethyl acetate, the n-butanol, an addictive and water, and the addictive comprises cyclodextrin; and preferably, the cyclodextrin comprises hydroxypropyl-β-cyclodextrin.

### Claim 2 (depends on 1)

The method according to claim 1, specifically comprising: conducting the primary separation on the Lindera aggregata leaf extract by the HSCCC, collecting eluates at 105 min to 115 min, 120 min to 130 min, 170 min to 185 min, and 270 min to 290 min, separately, to obtain the quercetin-3-O-β-D-arabinofuranoside, the mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside, the quercetin-3-O-rhamnopyranoside, and the kaempferol-7-O-α-L-rhamnopyranoside; wherein the HSCCC is conducted at 800 rpm, 25° C., and an ultraviolet detection wavelength of 280 nm and by using an upper phase as a stationary phase, and a lower phase as a mobile phase with a flow rate of 2 mL/min.

### Claim 3 (depends on 1)

The method according to claim 1, wherein in the first solvent system, the ethyl acetate, the n-butanol, the n-hexane, the glacial acetic acid and water have a volume ratio of 5:2:2:1.5:6.

### Claim 4 (depends on 1)

The method according to claim 1, specifically comprising: conducting the secondary separation on the mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside by the HSCCC, collecting eluates at 670 min to 710 min and 740 min to 790 min, separately, to separate the quercetin-3-O-β-D-glucoside from the quercetin-5-O-β-D-glucoside; wherein the HSCCC is conducted at 800 rpm, 5° C., and an ultraviolet detection wavelength of 254 nm and by using an upper phase as a stationary phase, and a lower phase as a mobile phase with a flow rate of 2 mL/min.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the second solvent system comprises the ethyl acetate, the n-butanol, the hydroxypropyl-β-cyclodextrin and water; and the hydroxypropyl-β-cyclodextrin and water form an acidic aqueous solution of the hydroxypropyl-β-cyclodextrin with a concentration of 0.05 mol/L.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the Lindera aggregata leaves and the adsorbent have a mass ratio of 1:0 to 2:1, preferably 1:1; and/or
the adsorbent comprises any one of silica gel, alumina, Florisil, and a molecular sieve SBA-15, preferably the silica gel.

### Claim 7 (depends on 1)

The method according to claim 1, specifically comprising the following steps:
drying, pulverizing, sieving the Lindera aggregata leaves, and mixing with the adsorbent for grinding, to form a Lindera aggregata leaf mixture;
conducting elution on the Lindera aggregata leaf mixture in a chromatographic column to obtain a Lindera aggregata leaf eluate; and
concentrating and drying the Lindera aggregata leaf eluate to obtain the Lindera aggregata leaf extract.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the grinding is conducted for 0 min to 6 min.

### Claim 9 (depends on 7)

The method according to claim 7, wherein an eluent used in the elution comprises ethanol and/or methanol, preferably 70% ethanol;
preferably, the eluent has a flow rate of 0.5 mL/min to 3 mL/min, more preferably 1 mL/min; and
preferably, the eluent has a volume of 1 BV to 6 BV, more preferably 5 BV.

### Claim 10 (depends on 1)

Use of the method according to claim 1 in rapid extraction, separation and purification of active ingredients in traditional Chinese medicine.

### Claim 11 (depends on 10)

The use according to claim 10, specifically comprising: conducting the primary separation on the Lindera aggregata leaf extract by the HSCCC, collecting eluates at 105 min to 115 min, 120 min to 130 min, 170 min to 185 min, and 270 min to 290 min, separately, to obtain the quercetin-3-O-β-D-arabinofuranoside, the mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside, the quercetin-3-O-rhamnopyranoside, and the kaempferol-7-O-α-L-rhamnopyranoside; wherein the HSCCC is conducted at 800 rpm, 25° C., and an ultraviolet detection wavelength of 280 nm and by using an upper phase as a stationary phase, and a lower phase as a mobile phase with a flow rate of 2 mL/min.

### Claim 12 (depends on 10)

The use according to claim 10, wherein in the first solvent system, the ethyl acetate, the n-butanol, the n-hexane, the glacial acetic acid and water have a volume ratio of 5:2:2:1.5:6.

### Claim 13 (depends on 10)

The use according to claim 10, specifically comprising: conducting the secondary separation on the mixture of quercetin-3-O-β-D-glucoside and quercetin-5-O-β-D-glucoside by the HSCCC, collecting eluates at 670 min to 710 min and 740 min to 790 min, separately, to separate the quercetin-3-O-β-D-glucoside from the quercetin-5-O-β-D-glucoside; wherein the HSCCC is conducted at 800 rpm, 5° C., and an ultraviolet detection wavelength of 254 nm and by using an upper phase as a stationary phase, and a lower phase as a mobile phase with a flow rate of 2 mL/min.

### Claim 14 (depends on 10)

The use according to claim 10, wherein the second solvent system comprises the ethyl acetate, the n-butanol, the hydroxypropyl-β-cyclodextrin and water; and the hydroxypropyl-β-cyclodextrin and water form an acidic aqueous solution of the hydroxypropyl-β-cyclodextrin with a concentration of 0.05 mol/L.

### Claim 15 (depends on 10)

The use according to claim 10, wherein the Lindera aggregata leaves and the adsorbent have a mass ratio of 1:0 to 2:1, preferably 1:1; and/or
the adsorbent comprises any one of silica gel, alumina, Florisil, and a molecular sieve SBA-15, preferably the silica gel.

### Claim 16 (depends on 10)

The use according to claim 10, specifically comprising the following steps:
drying, pulverizing, sieving the Lindera aggregata leaves, and mixing with the adsorbent for grinding, to form a Lindera aggregata leaf mixture;
conducting elution on the Lindera aggregata leaf mixture in a chromatographic column to obtain a Lindera aggregata leaf eluate; and
concentrating and drying the Lindera aggregata leaf eluate to obtain the Lindera aggregata leaf extract.

### Claim 17 (depends on 16)

The use according to claim 16, wherein the grinding is conducted for 0 min to 6 min.

### Claim 18 (depends on 16)

The use according to claim 16, wherein an eluent used in the elution comprises ethanol and/or methanol, preferably 70% ethanol;
preferably, the eluent has a flow rate of 0.5 mL/min to 3 mL/min, more preferably 1 mL/min; and
preferably, the eluent has a volume of 1 BV to 6 BV, more preferably 5 BV.
